 |
|
|
 |
OMERACT 8 International Consensus Conference on Outcome Measures in Rheumatology Clinical Trials, St. Julian's Bay, Malta, May 10-14, 2006 Introduction
Biomarkers and Surrogate Endpoints The
WHO
International Classification of Functioning, Disability and Health: A
Conceptual Model and Interface for the OMERACT Process Definitions
and Validation Criteria for Biomarkers and Surrogate Endpoints:
Development and Testing of a Quantitative Hierarchical Levels of
Evidence Schema Simulation
Studies of Surrogate Endpoint Validation Using Single Trial and
Multitrial Statistical Approaches Synovial
Macrophages as a Biomarker of Response to Therapeutic Intervention in
RA: Standardization and Consistency Across Centers Testing
of
the Preliminary OMERACT Validation Criteria for a Biomarker to Be
Regarded as Reflecting Structural Damage Endpoints in RA Clinical
Trials: The Example of CRP Development
of Draft Validation Criteria for a Soluble Biomarker to Be Regarded
as a Valid Biomarker Reflecting Structural Damage Endpoints in RA and
SpA Clinical Trials Assessing
Single Joints in Arthritis Clinical Trials Imaging Summary
Findings of a Systematic Review of the Ultrasound Assessment of
Synovitis The
OMERACT
Ultrasound Group: Status of Current Activities and Research
Directions The
OMERACT
MRI Inflammatory Arthritis Group — Advances and Priorities A
Multireader
Reliability Study Comparing Conventional High-Field MRI with
Extremity Low-Field MRI in RA A
Multicenter
Reliability Study of Extremity-MRI in the Longitudinal Evaluation of
RA Developing
a
MRI Scoring System for Peripheral Psoriatic Arthritis Scoring
Inflammatory Activity of the Spine by MRI in AS: A Multireader
Experiment Is
There a
Preferred Method for Scoring Activity of the Spine by MRI in AS? Computer
Based Methods for Measurement of Joint Space Width: Update of an
Ongoing OMERACT Project Repair
in RA,
Current Status. Report of a Workshop at OMERACT 8 Outcome Measures Outcome
Measures in PsA Consensus
on
a Core Set of Domains for PsA Patient
Perspective: Reasons and Methods for Measuring Fatigue in RA Patient
Perspective: Fatigue as a Recommended Patient Centered Outcome
Measure in RA Considerations
and Preliminary Proposals for Defining a Reference Case for Economic
Evaluations in AS Rationale
and
Strategies for Reevaluating the ACR20 Minimal
Clinically Important Improvement and Patient Acceptable Symptom State
for Subjective Outcome Measures in Rheumatic Disorders SSc
—
Continuing Progress in Developing Clinical Measures of Response
Workshops and Special Interest Groups The
Future of
Damage Assessment in Vasculitis Worker
Productivity Outcome Measures in Arthritis Outcome
Evaluations in Gout Preliminary
Development of a Responder Index for Chronic Low Back Pain Development
of the Effective Musculoskeletal Consumer Scale Standardizing
Assessment and Reporting of Adverse Effects in Rheumatology Clinical
Trials II: the Rheumatology Common Toxicity Criteria v.2.0 Fibromyalgia
Syndrome Improving
Patient Reported Outcomes Using Item Response Theory and Computerized
Adaptive Testing OMERACT/OARSI
Initiative to Define States of Severity and Indication for Joint
Replacement in Hip and Knee OA Acknowledgment.........1436
|
